Champions Oncolog
(CSBR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 04/30
| 10-2010 | 07-2010 | 04-2010 | 01-2010 | 10-2009 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,263 | 2,088 | 2,572 | 1,479 | 394 |
| Receivables | 1,295 | 33 | 89 | 414 | 72 |
| TOTAL | $2,856 | $2,552 | $3,158 | $2,655 | $1,158 |
| Non-Current Assets | |||||
| PPE Net | 109 | 115 | 105 | 97 | 97 |
| Intangibles | 669 | 669 | 669 | 669 | 669 |
| TOTAL | $778 | $784 | $774 | $766 | $766 |
| Total Assets | $3,634 | $3,336 | $3,932 | $3,421 | $1,924 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,382 | 1,109 | 944 | 886 | 1,185 |
| Accrued Expenses | 244 | 309 | 236 | 205 | 106 |
| TOTAL | $2,200 | $1,973 | $2,090 | $1,399 | $1,422 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 574 | 555 | 910 | 308 | 131 |
| Other Non-Current Liabilities | 47 | 89 | 265 | 296 | 219 |
| TOTAL | $47 | $89 | $265 | $296 | $219 |
| Total Liabilities | $2,247 | $2,062 | $2,355 | $1,695 | $1,641 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 3,069 | 2,966 | 2,974 | 2,964 | 2,738 |
| Common Shares | 37 | 37 | 37 | 37 | 34 |
| Retained earnings | -13,325 | -13,271 | -12,680 | -12,128 | -11,344 |
| Other shareholders' equity | -1,072 | -1,000 | -973 | -196 | -190 |
| TOTAL | $1,387 | $1,274 | $1,577 | $1,726 | $283 |
| Total Liabilities And Equity | $3,634 | $3,336 | $3,932 | $3,421 | $1,924 |